Blood Pressure Classification Using the 2017 ACC/AHA Guideline and Heart Failure in Patients With Cancer.

Hidehiro KanekoYuichiro YanoHokyou Lee Hyeok-Hee LeeAkira OkadaYuta Suzuki Hidetaka Itoh Satoshi MatsuokaKatsuhito FujiuNobuaki MichihataTaisuke JoNorifumi TakedaHiroyuki MoritaAkira NishiyamaKoichi Node Hyeon Chang KimHideo YasunagaIssei Komuro

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)

Medication-naïve stage 1 and 2 hypertension was associated with a greater risk of HF and other CVD events in patients with cancer. Our results suggest the importance of multidisciplinary collaboration (eg, oncologists and cardiologists) to establish the optimal management strategy for hypertension in patients with cancer.

Keyphrases

blood pressure
heart failure
hypertensive patients
heart rate
machine learning
acute heart failure
deep learning
healthcare
blood glucose
type diabetes
left ventricular
atrial fibrillation
emergency department
insulin resistance
cardiac resynchronization therapy
advanced cancer
palliative care
weight loss